Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jiac.2020.12.001 http://scihub22266oqcxt.onion/10.1016/j.jiac.2020.12.001 33328135!7836222!33328135     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33328135&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Infect+Chemother 2021 ; 27 (2): 387-389 Nephropedia Template TP {{tp|p=33328135|t=2021. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient |pdf=|usr=}}{{33328135}} gab.com Text Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient JO: J Infect Chemother http://www.kidney.de/pget.php?&tw=1&pmid=33328135 #FOAvip The duration of viral shedding of SARS-CoV-2 is usually less than 10 days. We experienced a COVID-19 case with prolonged viral shedding for 2 months. His cell mediated immunity has been depressed (CD4(+)T cell <100/mul) due to advanced malignant lymphoma and chemotherapy which had been completed 4 months prior to the onset of symptoms of COVID-19. We administered several treatments against COVID-19, however the results of Polymerase Chain Reaction (PCR) from nasopharyngeal specimens remained positive to SARS-CoV-2 for 2 months. Moreover, virus isolation assays performed on Day 59 also remained positive. He was finally discharged on Day 69 with two consecutive negative PCR results for SARS-CoV-2. Immunocompromised status may prolong viral shedding and it is therefore important for the clinician to take into account this when assessing such patients. Twit Text FOAVip Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient ????J Infect Chemother http://www.kidney.de/pget.php?&tw=1&pmid=33328135 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33328135 #FOAvip English Wikipedia <ref>{{Cite pmid|33328135}}</ref> Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient #MMPMID33328135 Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N J Infect Chemother 2021[Feb]; 27 (2): 387-389 PMID33328135show ga The duration of viral shedding of SARS-CoV-2 is usually less than 10 days. We experienced a COVID-19 case with prolonged viral shedding for 2 months. His cell mediated immunity has been depressed (CD4(+)T cell <100/mul) due to advanced malignant lymphoma and chemotherapy which had been completed 4 months prior to the onset of symptoms of COVID-19. We administered several treatments against COVID-19, however the results of Polymerase Chain Reaction (PCR) from nasopharyngeal specimens remained positive to SARS-CoV-2 for 2 months. Moreover, virus isolation assays performed on Day 59 also remained positive. He was finally discharged on Day 69 with two consecutive negative PCR results for SARS-CoV-2. Immunocompromised status may prolong viral shedding and it is therefore important for the clinician to take into account this when assessing such patients. |*Immunocompromised Host[MESH] |*Virus Shedding[MESH] |Antiviral Agents/therapeutic use[MESH] |COVID-19/complications/*immunology/therapy/virology[MESH] |Humans[MESH] |Lymphoma/*complications/virology[MESH] |Male[MESH] |Middle Aged[MESH] |Nasopharynx/virology[MESH] |RNA, Viral/analysis[MESH] |Reverse Transcriptase Polymerase Chain Reaction/methods[MESH] |SARS-CoV-2/*isolation & purification[MESH] |Time Factors[MESH]Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient(epmc).pdf DeepDyve Pubget Overpricing